logo
Vijay Kedia portfolio: Multibagger small-cap stock Advait Energy hits 20% upper circuit as ace investor picks stake

Vijay Kedia portfolio: Multibagger small-cap stock Advait Energy hits 20% upper circuit as ace investor picks stake

Mint12-06-2025
Vijay Kedia portfolio: Multibagger small-cap stock Advait Energy Transitions surged 20% to hit the upper price band in trade on Thursday, June 12, after data showed that ace investor Vijay Kedia has picked up a stake in the company via bulk deals a day ago.
The data available on BSE showed that Vijay Kedia acquired 100,000 shares of the company at an average price of ₹ 1,725, taking the deal size to ₹ 17.25 crore. The ace investor acquired the stake via his investment firm, Kedia Securities.
Prior to this, Vijay Kedia's name did not appear in the shareholding pattern, suggesting either this is a fresh purchase or the stake was less than 1%, as then companies are not required to disclose the names of shareholders.
Another marquee investor — Ashish Kacholia — also holds stake in the small-cap stock Advait Energy Transitions. Kacholia has a 2.67% holding in the company as of March 2025.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Tata Power bets on renewable energy to drive future growth
Tata Power bets on renewable energy to drive future growth

Time of India

time4 minutes ago

  • Time of India

Tata Power bets on renewable energy to drive future growth

ET Intelligence Group: Tata Power Company (TPCL) is ramping up investments in renewables, which have emerged as a key growth driver for profit and revenue. The segment's share of operating profit rose to 26.3% in FY25 from 19.2% in FY23. In the first quarter of FY26, this segment was the largest contributor to the company's operating profit before depreciation and amortisationm, or Ebitda. Renewables clocked an Ebitda of ₹1,567 crore, while TPCL's total Ebitda was ₹3,930 crore. Other divisions, including transmission and distribution (T&D), delivered an Ebitda of ₹ 1,345 crore, while that from thermal generation, coal, and hydro segment was ₹974 crore. Finance Value and Valuation Masterclass - Batch 4 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program Finance Value and Valuation Masterclass - Batch 3 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals By Vaibhav Sisinity View Program Finance Value and Valuation Masterclass - Batch 2 By CA Himanshu Jain View Program Finance Value and Valuation Masterclass Batch-1 By CA Himanshu Jain View Program The company plans to add 1.7 gigawatts (GW) of renewable energy capacity by the end of the current financial year, which will take its total installed renewables capacity to approximately 6.6 GW. The total clean energy capacity- including renewable, hydro, hybrid and Waste Heat Recovery Systems-was nearly 7 GW as of June. Adani Green Energy , in comparison, had a total renewable energy capacity of 14.2 GW at the end of FY25, comprising 10.1 GW of solar, 2 GW of wind, and 2.1 GW of hybrid power. Praveer Sinha, MD and CEO, TPCL, stated during an earnings call that the company's balance sheet was sturdy in spite of a sustained capital expenditure. "We spent in the June quarter ₹3,700 crore against our full year plan of ₹25,000 crore and we are on track to implement all those projects." The company is currently executing nearly 5.5 GW of renewable energy capacity. It has 2.8 GW of pumped hydro projects in progress, with 1 GW already under construction and the remaining 1.8 GW scheduled to begin within the next nine months. In addition, work is underway on a 600-megawatt hydro project in Bhutan with plans to scale the total capacity to nearly 5 GW over the next few years. "These projects will give us either similar or better returns than what we will do in any other project," Sinha said. The company's net debt has risen by nearly ₹2,900 crore to ₹47,578 crore in the first quarter of the current financial year due to higher capex and working capital requirements. JM Financial Institutional Securities expects the company's net profit to grow by 13% annually between FY25 and FY28. The broking firm has retained a 'buy' call on the stock with a target price of ₹436. The stock was last traded at ₹384.5 on Tuesday on the BSE.

Hindalco's 30% net jump in June quarter puts Novelis revival in strong focus
Hindalco's 30% net jump in June quarter puts Novelis revival in strong focus

Time of India

time15 minutes ago

  • Time of India

Hindalco's 30% net jump in June quarter puts Novelis revival in strong focus

The worst is over for Novelis on several fronts, said Satish Pai, managing director of Hindalco Industries . "By the second half of this year, you should start to see a very positive turn for Novelis," he said on Tuesday. Hindalco Industries, which reported consolidated earnings on Tuesday, posted a 30% rise in consolidated net profit for the June quarter at ₹4,004 crore, with consolidated revenue from operations up 13% at ₹64,232 crore. Finance Value and Valuation Masterclass - Batch 4 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program Finance Value and Valuation Masterclass - Batch 3 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals By Vaibhav Sisinity View Program Finance Value and Valuation Masterclass - Batch 2 By CA Himanshu Jain View Program Finance Value and Valuation Masterclass Batch-1 By CA Himanshu Jain View Program Novelis, the wholly-owned US-based subsidiary, saw a 36% drop in net income for the June quarter at $96 million, while adjusted EBITDA per tonne of aluminium was $432, down 18% year-on-year. Structurally higher scrap prices dented performance during the quarter, Novelis said on Monday. "Scrap spreads have started to improve, particularly in the US. So, we are now hoping that will get better in the coming quarters," Pai said on Tuesday. "The supply of scrap in the US has also gone up, so scrap spreads are no longer a headwind, but have started to become a tailwind," he told reporters after the earnings call. The September and December quarters of last fiscal marked the peak in scrap prices, Pai said, with prices now turning favourable. Live Events While the June quarter marks the "bottom" in many ways, the September quarter will be similar. "By Q3 and Q4 of this year, you are going to see a much stronger and healthier Novelis," Pai said. Earnings in the second half will reflect the impact of scrap spread mitigation, cost reduction measures and improving spreads, he added. For the upstream aluminium business in India, Hindalco's EBITDA rose 17% year-on-year to ₹4,080 crore. Upstream EBITDA per tonne stood at $1,467, up 15% from a year earlier. In the downstream aluminium business, EBITDA per tonne jumped 92% year-on-year to $264, while EBITDA hit a record ₹229 crore, up 108% year-on-year. In the copper business, EBITDA was ₹673 crore, with sharply lower TC/RCs offset by higher sulphuric acid realisations, the company said. At the consolidated level, EBITDA rose 9% year-on-year to ₹8,673 crore. Hindalco announced earnings during market hours, with its shares closing at ₹666.95 on the BSE, down 0.7% from the previous close.

Zydus Lifesciences Q1 net profit rises 3% to Rs 1,467 crore
Zydus Lifesciences Q1 net profit rises 3% to Rs 1,467 crore

Time of India

time2 hours ago

  • Time of India

Zydus Lifesciences Q1 net profit rises 3% to Rs 1,467 crore

Zydus Lifesciences on Tuesday said its consolidated net profit increased 3 per cent year-on-year to Rs 1,467 crore for the first quarter ended June 30, 2025, riding on strong performance across domestic and international markets. The drug maker reported a net profit of Rs 1,420 crore for the April-June quarter of the last fiscal. Revenue from operations rose to Rs 6,574 crore for the June quarter as compared with Rs 6,207 crore in the year-ago period, the drug maker said in a statement. "Our Q1 FY2026 performance reflects the results of our disciplined execution, with most of our key businesses meeting expectations," Zydus Lifesciences MD Sharvil Patel said. The company remains firmly on track to achieve FY2026 aspirations and is excited about the upcoming developments on the innovation front, which will open up new avenues for sustainable growth, he added. The drug maker said its domestic business revenue increased 6 per cent year-on-year to Rs 2,374 crore in the June quarter. Revenues of the formulations business saw a growth of 8 per cent year-on-year to Rs 1,519 crore in the year-ago period. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Original Adidas Three Combo Track-Pants With Up To 60% Off Adidas India Shop Now Undo Consumer wellness business revenue grew 2 per cent year-on-year to Rs 855 crore in the first quarter ended June 30, 2025. US formulations business revenue grew 3 per cent year-on-year to Rs 3,182 crore in the June quarter. Shares of the company on Tuesday ended 0.27 per cent up at Rs 958.05 apiece on BSE. Stay informed with the latest business news, updates on bank holidays , public holidays , current gold rate and silver price .

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store